Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis

Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. All patients who underwent temporal...

Full description

Saved in:
Bibliographic Details
Published inRheumatology (Oxford, England) Vol. 54; no. 3; pp. 554 - 558
Main Authors Lally, L., Pernis, A., Narula, N., Huang, W.-T., Spiera, R.
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.03.2015
Subjects
Online AccessGet full text
ISSN1462-0324
1462-0332
1462-0332
DOI10.1093/rheumatology/keu364

Cover

Loading…
Abstract Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6. Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone. Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.
AbstractList Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA.OBJECTIVEAberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA.All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6.METHODSAll patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6.Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone.RESULTSNineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone.Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.CONCLUSIONSubjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.
Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0-2, with a maximum possible score of 6. Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores (P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone. Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.
Objective. Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune response is recognized in the pathogenesis of GCA. The aim of this study was to assess ROCK activity in GCA. Methods. All patients who underwent temporal artery biopsy (TAB) at a tertiary care centre over 5 years were identified and charts reviewed. Subjects were categorized into three groups: TAB-positive GCA, TAB-negative GCA and age- and sex-matched controls. TABs were stained for phosphorylated ezrin/radixin/moesin (pERM), a surrogate of ROCK activity, and reviewed by a pathologist blinded to clinical status. Three areas were scored for staining intensity on a scale of 0–2, with a maximum possible score of 6. Results. Nineteen subjects with TAB-positive GCA, 17 with TAB-negative GCA and 18 controls were analysed. Compared with controls, GCA subjects with either positive or negative TABs had significantly higher pERM intensity scores ( P = 0.0109). Adjusting for diabetes, hypertension, prednisone and statin use, GCA subjects still had higher pERM scores [odds ratio 7.3 (95% CI 1.9, 25.9), P = 0.0046]. The high pERM score had a sensitivity of 90% and a negative predictive value of 91% for the diagnosis of GCA in those with a negative TAB, compared with 51% sensitivity for histopathology alone. Conclusion. Subjects with GCA had more intense pERM staining in TAB specimens compared with age- and sex-matched controls, regardless of whether TAB was positive or negative by routine histopathology, suggesting increased ROCK activity in GCA. The ROCK pathway warrants further investigation in GCA, as it may have diagnostic significance in enhancing the sensitivity of TAB.
Author Pernis, A.
Huang, W.-T.
Narula, N.
Spiera, R.
Lally, L.
Author_xml – sequence: 1
  givenname: L.
  surname: Lally
  fullname: Lally, L.
– sequence: 2
  givenname: A.
  surname: Pernis
  fullname: Pernis, A.
– sequence: 3
  givenname: N.
  surname: Narula
  fullname: Narula, N.
– sequence: 4
  givenname: W.-T.
  surname: Huang
  fullname: Huang, W.-T.
– sequence: 5
  givenname: R.
  surname: Spiera
  fullname: Spiera, R.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25213129$$D View this record in MEDLINE/PubMed
BookMark eNp9UUtP3DAQthAV719QqfKRy4IfSRxfkBCiBQmpl3K2HGe8a0jsYDug_fd4tQuiPfQ0I833mJnvGO374AGh75RcUCL5ZVzBPOochrBcXz7DzJtqDx3RqmELwjnb_-xZdYiOU3oihNSUtwfokNWMcsrkEdL33kTQCXocVwE_O196rE12ry6vsfM4wziFqAesY4a4xp0LU3KQsI1hxJPODnxO-M3lFV467TM2MOzQLrt0ir5ZPSQ429UT9Pjz9s_N3eLh96_7m-uHhalEnRc1CGBUV7WwDSHQMclkp4WRxra257ZvC0DUQojeGCsEF6SXkrbUdswIIfkJutrqTnM3Qm_KVmVrNUU36rhWQTv198S7lVqGV1VxXjVtXQTOdwIxvMyQshpd2tyiPYQ5KdrUgjPeEFGgP756fZp8_LUA5BZgYkgpglXG5fKqsLF2g6JEbTJUXzNU2wwLl__D_ZD_H-sdIG6qWw
CitedBy_id crossref_primary_10_1080_14737175_2017_1395700
crossref_primary_10_1016_j_berh_2016_05_001
crossref_primary_10_1007_s40266_015_0284_7
crossref_primary_10_1080_14397595_2016_1266070
crossref_primary_10_1146_annurev_med_051914_022120
crossref_primary_10_12688_f1000research_7522_1
crossref_primary_10_1097_BOR_0000000000000265
crossref_primary_10_1016_j_rdc_2014_10_001
crossref_primary_10_1016_j_clim_2021_108823
crossref_primary_10_1016_j_autrev_2023_103328
crossref_primary_10_1016_j_lpm_2016_11_033
crossref_primary_10_3899_jrheum_220012
crossref_primary_10_3904_kjm_2018_93_5_430
Cites_doi 10.1152/ajpheart.00327.2011
10.1038/sj.eye.6700677
10.1253/circj.CJ-10-0110
10.1053/sarh.2001.16650
10.1016/S1568-9972(03)00064-8
10.1002/art.33362
10.4049/jimmunol.178.3.1938
10.1016/S0140-6736(08)61077-6
10.1083/jcb.140.3.647
10.1172/JCI42856
10.4065/79.4.483
10.1097/BOR.0b013e32833ee946
10.1007/s00018-010-0460-1
10.1002/art.34327
10.7326/0003-4819-142-5-200503010-00011
10.1111/j.0105-2896.2009.00864.x
10.1002/art.1780330810
10.1136/ard.2008.088351
10.1002/art.11388
10.1136/annrheumdis-2012-201836
ContentType Journal Article
Copyright The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014
Copyright_xml – notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
– notice: The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2014
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1093/rheumatology/keu364
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1462-0332
EndPage 558
ExternalDocumentID PMC4334685
25213129
10_1093_rheumatology_keu364
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: T32 AR007517
– fundername: NIAMS NIH HHS
  grantid: T32-AR007517-30
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
29P
2WC
354
4.4
48X
53G
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAWTL
AAYXX
ABDFA
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABVGC
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADNBA
ADOCK
ADQBN
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AGINJ
AGKEF
AGORE
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIAGR
AIJHB
AJBYB
AJEEA
AJNCP
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CITATION
CS3
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBD
EBS
EE~
EJD
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MHKGH
N9A
NGC
NOMLY
NOYVH
NU-
NVLIB
O9-
OAUYM
OAWHX
OBH
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
RUSNO
RW1
RXO
SV3
TCURE
TEORI
TJX
TR2
VVN
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
ZY1
~91
.GJ
3O-
AAGKA
AAPGJ
AAWDT
ABNGD
ACFRR
ACUKT
ADMTO
AEHUL
AFFNX
AGQPQ
AHGBF
AQDSO
ATTQO
AZFZN
CAG
CGR
COF
CUY
CVF
ECM
EIF
EIHJH
FEDTE
HVGLF
NPM
NTWIH
O0~
O~Y
PB-
RIG
RNI
RZF
RZO
TMA
ZGI
7X8
5PM
ID FETCH-LOGICAL-c475t-5e7e21a457f600eb2929ba7c9cf8fd3fd8e7e75777dccf77370d99181fb2c7793
ISSN 1462-0324
1462-0332
IngestDate Thu Aug 21 18:02:51 EDT 2025
Thu Jul 10 17:02:08 EDT 2025
Mon Jul 21 05:37:42 EDT 2025
Tue Jul 01 01:36:32 EDT 2025
Thu Apr 24 23:10:16 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords giant cell arteritis
vasculitis
rho-associated kinases
Language English
License The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c475t-5e7e21a457f600eb2929ba7c9cf8fd3fd8e7e75777dccf77370d99181fb2c7793
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/rheumatology/article-pdf/54/3/554/6700289/keu364.pdf
PMID 25213129
PQID 1657323607
PQPubID 23479
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4334685
proquest_miscellaneous_1657323607
pubmed_primary_25213129
crossref_citationtrail_10_1093_rheumatology_keu364
crossref_primary_10_1093_rheumatology_keu364
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-03-01
PublicationDateYYYYMMDD 2015-03-01
PublicationDate_xml – month: 03
  year: 2015
  text: 2015-03-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Rheumatology (Oxford, England)
PublicationTitleAlternate Rheumatology (Oxford)
PublicationYear 2015
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References (11_48541577) 2011; 301
(9_35806208) 1998; 140
Hunder (13_9148981) 1990; 33
Varma (15_18126353) 2004; 18
Karassa (17_18707055) 2005; 142
(2_30897245) 2009; 68
Weyand (3_38110435) 2011; 23
Restuccia (20_40870751) 2012; 64
Biswas (7_36736544) 2010; 233
Proven (18_17855780) 2003; 49
Gonzalez-Gay (16_11044191) 2001; 30
Nunes (10_37743196) 2010; 67
Younge (14_18123319) 2004; 79
Weyand (19_18036490) 2004; 3
(4_43646735) 2013; 72
Li (8_23536804) 2007; 178
Terrier (5_41400410) 2012; 64
Zhou (12_37189433) 2010; 74
Salvarani (1_31572308) 2008; 372
Biswas (6_37892137) 2010; 120
14871649 - Autoimmun Rev. 2004 Jan;3(1):46-53
15069435 - Eye (Lond). 2004 Apr;18(4):384-8
18640460 - Lancet. 2008 Jul 19;372(9634):234-45
15065613 - Mayo Clin Proc. 2004 Apr;79(4):483-91
21953306 - Arthritis Rheum. 2012 Feb;64(2):549-56
22993227 - Ann Rheum Dis. 2013 Sep 1;72(9):1481-7
14558057 - Arthritis Rheum. 2003 Oct 15;49(5):703-8
11182025 - Semin Arthritis Rheum. 2001 Feb;30(4):249-56
9456324 - J Cell Biol. 1998 Feb 9;140(3):647-57
21622831 - Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96
2202311 - Arthritis Rheum. 1990 Aug;33(8):1122-8
18413441 - Ann Rheum Dis. 2009 Mar;68(3):318-23
20697158 - J Clin Invest. 2010 Sep;120(9):3280-95
20668910 - Cell Mol Life Sci. 2010 Nov;67(22):3823-36
20192994 - Immunol Rev. 2010 Jan;233(1):79-96
20424337 - Circ J. 2010 May;74(5):818-26
22147555 - Arthritis Rheum. 2012 Jun;64(6):2001-11
15738455 - Ann Intern Med. 2005 Mar 1;142(5):359-69
20827207 - Curr Opin Rheumatol. 2011 Jan;23(1):43-9
17237445 - J Immunol. 2007 Feb 1;178(3):1938-47
References_xml – volume: 301
  start-page: 287
  issn: 0363-6135
  year: 2011
  ident: 11_48541577
  publication-title: American Journal of Physiology - Heart and Circulatory Physiology
  doi: 10.1152/ajpheart.00327.2011
– volume: 18
  start-page: 384
  issn: 0950-222X
  issue: 4
  year: 2004
  ident: 15_18126353
  publication-title: Eye (London, England)
  doi: 10.1038/sj.eye.6700677
– volume: 74
  start-page: 818
  issn: 1346-9843
  issue: 5
  year: 2010
  ident: 12_37189433
  publication-title: Circulation journal : official journal of the Japanese Circulation Society
  doi: 10.1253/circj.CJ-10-0110
– volume: 30
  start-page: 249
  issn: 0049-0172
  issue: 4
  year: 2001
  ident: 16_11044191
  publication-title: Seminars in arthritis and rheumatism
  doi: 10.1053/sarh.2001.16650
– volume: 3
  start-page: 46
  issn: 1568-9972
  issue: 1
  year: 2004
  ident: 19_18036490
  publication-title: Autoimmunity reviews
  doi: 10.1016/S1568-9972(03)00064-8
– volume: 64
  start-page: 549
  issn: 0004-3591
  issue: 2
  year: 2012
  ident: 20_40870751
  publication-title: Arthritis and rheumatism
  doi: 10.1002/art.33362
– volume: 178
  start-page: 1938
  issn: 0022-1767
  issue: 3
  year: 2007
  ident: 8_23536804
  publication-title: The Journal of Immunology
  doi: 10.4049/jimmunol.178.3.1938
– volume: 372
  start-page: 234
  issn: 0140-6736
  issue: 9634
  year: 2008
  ident: 1_31572308
  publication-title: Lancet
  doi: 10.1016/S0140-6736(08)61077-6
– volume: 140
  start-page: 647
  issn: 0021-9525
  issue: 3
  year: 1998
  ident: 9_35806208
  publication-title: The Journal of Cell Biology
  doi: 10.1083/jcb.140.3.647
– volume: 120
  start-page: 3280
  issn: 0021-9738
  issue: 9
  year: 2010
  ident: 6_37892137
  publication-title: Journal of Clinical Investigation
  doi: 10.1172/JCI42856
– volume: 79
  start-page: 483
  issn: 0025-6196
  issue: 4
  year: 2004
  ident: 14_18123319
  publication-title: Mayo Clinic Proceedings
  doi: 10.4065/79.4.483
– volume: 23
  start-page: 43
  issn: 1040-8711
  issue: 1
  year: 2011
  ident: 3_38110435
  publication-title: Current opinion in rheumatology
  doi: 10.1097/BOR.0b013e32833ee946
– volume: 67
  start-page: 3823
  issn: 1420-682X
  issue: 22
  year: 2010
  ident: 10_37743196
  publication-title: Cellular and molecular life sciences : CMLS
  doi: 10.1007/s00018-010-0460-1
– volume: 64
  start-page: 2001
  issn: 0004-3591
  issue: 6
  year: 2012
  ident: 5_41400410
  publication-title: Arthritis and rheumatism
  doi: 10.1002/art.34327
– volume: 142
  start-page: 359
  issn: 0003-4819
  issue: 5
  year: 2005
  ident: 17_18707055
  publication-title: Annals of Internal Medicine
  doi: 10.7326/0003-4819-142-5-200503010-00011
– volume: 233
  start-page: 79
  issn: 0105-2896
  issue: 1
  year: 2010
  ident: 7_36736544
  publication-title: Immunological reviews
  doi: 10.1111/j.0105-2896.2009.00864.x
– volume: 33
  start-page: 1122
  issn: 0004-3591
  issue: 8
  year: 1990
  ident: 13_9148981
  publication-title: Arthritis and rheumatism
  doi: 10.1002/art.1780330810
– volume: 68
  start-page: 318
  issn: 0003-4967
  issue: 3
  year: 2009
  ident: 2_30897245
  publication-title: Annals of the Rheumatic Diseases
  doi: 10.1136/ard.2008.088351
– volume: 49
  start-page: 703
  issn: 0004-3591
  issue: 5
  year: 2003
  ident: 18_17855780
  publication-title: Arthritis and rheumatism
  doi: 10.1002/art.11388
– volume: 72
  start-page: 1481
  issn: 0003-4967
  issue: 9
  year: 2013
  ident: 4_43646735
  publication-title: Annals of the Rheumatic Diseases
  doi: 10.1136/annrheumdis-2012-201836
– reference: 15065613 - Mayo Clin Proc. 2004 Apr;79(4):483-91
– reference: 14871649 - Autoimmun Rev. 2004 Jan;3(1):46-53
– reference: 21953306 - Arthritis Rheum. 2012 Feb;64(2):549-56
– reference: 22993227 - Ann Rheum Dis. 2013 Sep 1;72(9):1481-7
– reference: 9456324 - J Cell Biol. 1998 Feb 9;140(3):647-57
– reference: 17237445 - J Immunol. 2007 Feb 1;178(3):1938-47
– reference: 15069435 - Eye (Lond). 2004 Apr;18(4):384-8
– reference: 2202311 - Arthritis Rheum. 1990 Aug;33(8):1122-8
– reference: 20424337 - Circ J. 2010 May;74(5):818-26
– reference: 21622831 - Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H287-96
– reference: 18640460 - Lancet. 2008 Jul 19;372(9634):234-45
– reference: 20192994 - Immunol Rev. 2010 Jan;233(1):79-96
– reference: 14558057 - Arthritis Rheum. 2003 Oct 15;49(5):703-8
– reference: 20668910 - Cell Mol Life Sci. 2010 Nov;67(22):3823-36
– reference: 20827207 - Curr Opin Rheumatol. 2011 Jan;23(1):43-9
– reference: 18413441 - Ann Rheum Dis. 2009 Mar;68(3):318-23
– reference: 15738455 - Ann Intern Med. 2005 Mar 1;142(5):359-69
– reference: 22147555 - Arthritis Rheum. 2012 Jun;64(6):2001-11
– reference: 11182025 - Semin Arthritis Rheum. 2001 Feb;30(4):249-56
– reference: 20697158 - J Clin Invest. 2010 Sep;120(9):3280-95
SSID ssj0005138
Score 2.2226698
Snippet Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17 immune...
Objective. Aberrant rho kinase (ROCK) activity is implicated in the pathogenesis of several vascular diseases and is associated with Th17 differentiation. Th17...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 554
SubjectTerms Aged
Aged, 80 and over
Basic and Translational Science
Biomarkers - metabolism
Biopsy
Case-Control Studies
Cell Differentiation
Cytoskeletal Proteins - metabolism
Female
Giant Cell Arteritis - diagnosis
Giant Cell Arteritis - metabolism
Giant Cell Arteritis - pathology
Humans
Male
Membrane Proteins - metabolism
Microfilament Proteins - metabolism
Predictive Value of Tests
rho-Associated Kinases - metabolism
Sensitivity and Specificity
Temporal Arteries - metabolism
Temporal Arteries - pathology
Th17 Cells - pathology
Title Increased rho kinase activity in temporal artery biopsies from patients with giant cell arteritis
URI https://www.ncbi.nlm.nih.gov/pubmed/25213129
https://www.proquest.com/docview/1657323607
https://pubmed.ncbi.nlm.nih.gov/PMC4334685
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKkBAvaHyXDWQk3kqyxh9x-jghYELbHlAn-hY5jkOrVemUJRLbP8K_yzl2EndME-MlShz3lPp-OZ-du98h9EHoWUaLnAXTTMUB44oFMK-TgEkOzkUki2mbKHxyGh-dsW8LvhiNfntRS02dher61ryS_9EqtIFeTZbsPTTbC4UGOAf9whE0DMd_0jG83CamHHzGarmZnK9KOG_ZMdqCECaC0RJPrSdt5ObVJFttLi5hbWyzShynqktw-wlAqSdmI9_2NmRHvuv6fakbcG8tZ5MhKf3VxcW7QiDepsKxdBWsj8PB9lalK33ct53KqllLm_A14MvtYP8Ig3nob0pEfIjKcnaUxQTabHp0qP02umV8LYO0Axn1LCl3d7S7Sm6195YLq_IGAC7PdUNjNkxw3Uf9G_NeH41ov8PT1BeTWiEP0EMC6w9TGuPrwosditoS6f2_7OisZvTAF3JghWy7PH-tY26G43r-zXwXPXELE3xoUfYUjXT5DD06caEXz5HswYYBbNiCDXdgw6sSd2DDFmy4Axs2YMMd2LABG27Bhg3YcA-2F-jsy-f5p6PA1ecIFBO8DrgWmkSScVGA26wzAq52JoWaqSIpcrAACXQQXAiRK1UIQcU0h-VIEhUZUQImhpdop9yU-jXCOorihLKCkVwaFxNkybxguY4zaZJYx4h0Q5gqR15vaqis0zuUN0Yf-x9dWO6Wu7u_73STgo01QyBLvWku0yjmghIaT8UYvbK66gUS8H8pOM1jJLa02Hcw_O3bd8rVsuVxZ5SyOOFv7veYe-jx8Mbto526avRbcIzr7F0L0j8UjMT3
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+rho+kinase+activity+in+temporal+artery+biopsies+from+patients+with+giant+cell+arteritis&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Lally%2C+L.&rft.au=Pernis%2C+A.&rft.au=Narula%2C+N.&rft.au=Huang%2C+W.-T.&rft.date=2015-03-01&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=54&rft.issue=3&rft.spage=554&rft.epage=558&rft_id=info:doi/10.1093%2Frheumatology%2Fkeu364&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_rheumatology_keu364
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon